Answers are grounded in this paper and cite their sources.
Influvac® Tetra elicited an adequate immune response with a favorable safety profile which was comparable with the reference vaccine. (Clinical trial registry number: CTRI/2018/02/012222).
No takes yet. Share an insight, caveat, or question.
Basu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: